Separating by subtype, we noticed the same trends of ALDH1A3 levels correlations with EMT scores in ER+, HER2+, and TNBC, especially in ER+ breast cancers (Supplemental Fig. S12). This evidence concerns the gene ALDH1A3 and breast carcinoma.